BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Görür K, Kandemir O, Unal M, Ozcan C. The effect of recombinant interferon alpha treatment on hearing thresholds in patients with chronic viral hepatitis B. Auris Nasus Larynx. 2003;30:41-44. [PMID: 12589849 DOI: 10.1016/S0385-8146(02)00063-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Interferon alfa. Meyler's Side Effects of Drugs 2016. [DOI: 10.1016/b978-0-444-53717-1.00900-8] [Reference Citation Analysis]
2 Gozdas HT, Karabay O. Reversible bilateral ototoxicity in a patient with chronic hepatitis B during peginterferon alpha-2a treatment. Indian J Pharmacol 2015;47:121-2. [PMID: 25821325 DOI: 10.4103/0253-7613.150377] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
3 Asal S, Sobhy O, Ismail O, Bedewy E. Study of the effect of combined interferon and ribavirin therapy on the hearing profile of hepatitis C virus patients. Egypt J Otolaryngol 2015;31:237-243. [DOI: 10.4103/1012-5574.168359] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
4 Sharifian MR, Kamandi S, Sima HR, Zaringhalam MA, Bakhshaee M. INF- α and ototoxicity. Biomed Res Int 2013;2013:295327. [PMID: 23984336 DOI: 10.1155/2013/295327] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
5 Jain S, Midha V, Sood A. Unilateral hearing loss due to pegylated interferon-α2b and ribavirin therapy. Indian J Gastroenterol 2011;30:239-40. [PMID: 21986854 DOI: 10.1007/s12664-011-0126-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
6 Shabana MI, Amer AR, Dabbous AO, Al-sunni AA. Hearing profile in hepatitis C virus patients under dual treatment with interferon and ribavirin. Audiological Medicine 2010;8:142-153. [DOI: 10.3109/1651386x.2010.515708] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 ANTIVIRAL DRUGS, INCLUDING IMMUNOGLOBULINS AND INTERFERONS. Meyler's Side Effects of Antimicrobial Drugs 2010. [DOI: 10.1016/b978-0-444-53272-5.50006-6] [Reference Citation Analysis]
8 Elloumi H, Houissa F, Hadj NB, Gargouri D, Romani M, Kharrat J, Ghorbel A. Sudden hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment. World J Gastroenterol 2007; 13(40): 5411-5412 [PMID: 17879419 DOI: 10.3748/wjg.v13.i40.5411] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
9 Block F. Hörstörungen. Medikamentös induzierte neurologische und psychiatrische Störungen. [DOI: 10.1007/3-540-28604-7_16] [Reference Citation Analysis]
10 Mehmet A, Yilmaz N, Zorludemir S, Güleryüz A, Acoskun B, Haciyakupoglu GM. Interferon-alpha2b may impair myelinization of rat optic nerve. Adv Ther 2006;23:23-32. [PMID: 16644604 DOI: 10.1007/BF02850343] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Vial T, Descotes J, Braun F, Behrend M. Drugs that act on the immune system: cytokines and monoclonal antibodies. Side Effects of Drugs Annual 28 2005. [DOI: 10.1016/s0378-6080(05)80459-3] [Reference Citation Analysis]
12 Formann E, Stauber R, Denk DM, Jessner W, Zollner G, Munda-Steindl P, Gangl A, Ferenci P. Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirin. Am J Gastroenterol 2004;99:873-7. [PMID: 15128353 DOI: 10.1111/j.1572-0241.2004.30372.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]